GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 23, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, transaction
TL;DR
GSK is buying back its own stock, signaling confidence.
AI Summary
GSK plc announced on May 23, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of share transactions and does not indicate any new or significant risks.
Key Players & Entities
- GSK plc (company) — The company making the share purchases.
- Citigroup Global Markets Limited (company) — The corporate stockbroker acting on behalf of GSK plc.
- May 23, 2025 (date) — The date of the announcement and the transactions.
FAQ
What is the total number of GSK plc ordinary shares purchased?
The filing states that GSK plc has purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity.
What is the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount spent on the purchase of GSK plc's ordinary shares.
Who is acting as GSK plc's corporate stockbroker for these transactions?
Citigroup Global Markets Limited is acting as GSK plc's corporate stockbroker.
What is the par value of GSK plc's ordinary shares?
The ordinary shares of GSK plc have a par value of 31 1/4 pence each.
When was this report filed with the SEC?
This Form 6-K report was filed with the SEC on May 23, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 23, 2025 regarding GSK plc (GLAXF).